3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
12
Lymphoma
12
Leukemia
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Hodgkin Disease
7
Sarcoma
6
Neoplasms
6
Hematologic Neoplasms
6
Myelodysplastic Syndromes
5
Leukemia, Myeloid, Acute
5
Neuroblastoma
4
Multiple Myeloma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Myeloproliferative Disorders
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Breast Neoplasms
3
Vomiting
2
Testicular Neoplasms
2
Recurrence
2
Osteosarcoma
2
Neoplasm Metastasis
2
Nausea
2
Burkitt Lymphoma
2
Thalassemia
1
Teratoma
1
Seminoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Interventions
Gemcitabine
13
Cisplatin
8
Capecitabine
8
Fluorouracil
5
pembrolizumab
4
Oxaliplatin
4
Sorafenib
3
Leucovorin
3
Erlotinib Hydrochloride
3
trametinib
2
regorafenib
2
durvalumab
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Magnetic Resonance Spectroscopy
2
Lapatinib
2
trifluridine tipiracil drug combination
1
tremelimumab
1
spartalizumab
1
seribantumab
1
olutasidenib
1
olaparib
1
devimistat
1
derazantinib
1
dehydroftorafur
1
cediranib
1
cabozantinib
1
Trifluridine
1
Trastuzumab
1
Therapeutics
1
Sutures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Bile Duct Neoplasms
×
Mesna
×
Clear all
No trials found.